03:39 AM EDT, 10/31/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on October 28, 2025, sold 40,000 shares in Arcutis Biotherapeutics ( ARQT ) for $1,001,032. Following the Form 4 filing with the SEC, Watanabe has control over a total of 1,039,574 common shares of the company, with 806,440 shares held directly and 233,134 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000180106125000008/xslF345X05/wk-form4_1761865337.xml